Abstract --In this study, a linear, transrectal,
INTRODUCTION
Prostate Disease is among the leading causes of morbidity and mortality in the United States. In 1999, there will be an estimated 179,300 new cases of prostate cancer, making it the most frequently diagnosed cancer in the population [l] . This year, 37,000 men will die from prostate carcinoma, second only to lung cancer in neoplasia related fatalities. Benign prostatic hyperplasia (BPH) or prostatism is one of the leading causes of morbidity. Studies have shown that 50% of all males in their fifties and 90% of males in their nineties exhibit some pathological evidence of BPH {Berry1994). The high incidences of both prostate cancer and BPH have prompted a large amount of investigation in the treatment of these diseases.
To deliver higher powers at fixed focal distance, spherical-curved transducers housed in intracavitaly applicators have been developed for transrectal treatment of the prostate. These transducers have been used to treat benign prostatic hyperplasia [2] and prostate cancer [3] . Fixed focus transducers are limited by their inability to treat large prostate volumes. In addition, these trials were done with 0-7803-5722-1/99/$10.00 Q 1999 IEEE limited thermometry, so monitoring of ablated regions was inadequate.
Linear planar phased arrays were proposed as another alternative [4] . Linear arrays trade off the high gain natural focus of spherical arrays for the ability to electronically move the focus in the depth and axial directions. Recently, linear phased arrays for prostate therapy have been fabricated and tested [5] [6] . In the Hutchinson study, a 62 element aperiodic array was developed and tested in vivo.
These ablation experiments were performed with M R I guidance and thermometry, which allows for thermal monitoring at high spatial (-1 mm) and temporal (-4 seconds) resolution. The study showed that a MM-compatible linear ultrasound applicator can create small lesions in in vivo rabbit thigh muscle while allowing temperature monitoring with MRI. However, since the Hutchinson array was linear, the focus was only steerable in 2 dimensions.
In order for focused ultrasound surgery to become an accepted treatment method for prostate cancer, ultrasound arrays that can ablate large prostate volumes while allowing continuous thermal monitoring need to be developed. The primary goal of this research was to develop and test an MMcompatible intracavitary ultrasound phased array capable of whole prostate ablation.
MATERIALS AND METHODS

Fabrication Materials and Techniques
One facet of this study was to improve upon the current materials and manufacturing techniques used in creating linear ultrasound phased arrays for thermal therapy. A series of test arrays were constructed to evaluate transducer interconnect and grounding techniques. Each test array was fabricated from 1.1 MHz PZT-4 pieces (ED0 EC-69, Salt Lake City, UT). To match the element sizes of the proposed array, rectangular PZT pieces were diced into 15 mm x 1 mm and 15 x 1.15 mm elements with kerf size of 0.11 mm (NIH Transducer Resource Center, Penn State University, PA). The transducer kerfs were tilled with degassed two-part (%:l) VI-SIL V-IO22 silicone (Loctite Corp.).
A Kapton flexible interconnect was developed to reduce electrical crosstalk and to tightly pack the signal and ground lines.
A 11-line flexible printed circuit with a ground plane was fabricated (Advanced Electronics, Minneapolis, W). The signal lines were made with 2 ounce copper, and the interconnect had a cross-sectional dimensions of 8 mm x 0.2 mm. Multiple flexible circuits could be layered to provide connections for additional elements. Transducer elements were soldered to the flex circuit.
Grounding the elements of transducers has historically been a problem in phased arrays with numerous small elements. Conductive silver epoxies and direct soldering were compared as means to attach 0.025 mm silver foil to one end of the transducer elements' ground electrode.
Acoustic efficiency, power, and coupling tests were performed to gauge the performance of the different grounding techniques with the Kapton flexible interconnect. Acoustic efficiency measurements were made using a radiation force technique {Stewartl982]. Maximum power was measured by progressively increasing the electrical power to an array element and measuring the acoustic output power until acoustic efficiencies began to drop more than 10%. Inter-element coupling was tested by measuring the acoustic efficiency when adjacent array elements were electrically driven in-phase and out-ofphase (180'). The difference in the in-phase and outof-phase efficiency measurements gives a measure of the inter-element coupling.
Construction of Phased Array System for Transrectal Ablation
The 62 element linear phased array was constructed from 1 .l MHz resonant PZT-4 (ED0 EC-69) with the dice and fill technique detailed in the previous section. The array incorporates 31 l .O x 15 mm elements and 3 I 1.15 x I5 mm elements that are randomly ordered (with total dimensions of 15 mm x 75 mm). The particular aperiodic geometry, i.e. the ordering, used in this array comes from a previous simulation and optimization study that showed significant reduction in grating lobe structure with aperiodic linear geometries [7] . Acoustic simulations of this array geometry demonstrated that foci with minimal lobe structure can be generated in a 3 cm x 6 cm area 3 cm from the array surface. High intensity foci were steered by phasing the array. The required phase for each element was calculated using the differences in path length from the center of each element to the desired focus. The linear phased array transducer was incorporated into an intracavitary applicator suitable for transrectal use. In order to allow full 3D scanning of the focus and thus complete coverage of the prostate volume, a rotational axis was incorporated in the design. The applicator was designed to be MRI compatible, so no ferromagnetic materials were used.
The applicator was constructed from polycarbonate and acrylic, and nylon screws and polymer adhesives were used in assembly. The ultrasonic motor (Shensei USR 60-N4, Japan) used for transducer rotation was also MRI compatible. The motor shaft position was tracked with a high-speed rotary encoder (MTL ME30-10000 C, Japan). Figure  1 above shows a detailed schematic of the transrectal applicator. The array was driven with a 64-channel custom designed amplifier system (Daum1998A). The acoustic efficiency of the 62-element array as measured by radiation force was 52% while phasing.
Evaluation of Phased Array in Ex Vivo and In Vivo Tissues
Two sets of tissue experiments were performed to verify the intracavitary array's capabilities. First, ex vivo bovine (fresh beef round) experiments were performed to demonstrate the three dimensional range of the array. Second, in vivo rabbit thigh experiments were used to investigate the array's ability to coagulate large tissue volumes. All experiments were performed with MRI guidance and thermometry.
The ex vivo specimen or in vivo tissue was placed in the bore of a clinical 1.5 Tesla Signa MR imager (GE Medical Systems, Milwaukee, W). Prior to sonications, fast spin-echo(FSE) Ti-weighted were used to position the array with respect to the specimen. Temperature images were obtained using the proton chemical shift technique
[8]. These images were acquired every 4-6 seconds during sonication and cooling. FSE T2-weighted images were used in the in vivo experiments to identify the focused ultrasound lesions and measure their sizes.
To demonstrate the axial range of the phased array, the focus was electrically moved (by phasing the elements) in 5 mm increments along the long axis of the array at a radial depth of 4 cm.
All sonications were done at low power, 25 electrical watts (13 acoustic watts assuming 52% efficiency), for 20 seconds. The transverse range of the phased array was verified by generating 4 cm-deep scanned foci at different motor positions. The transducer was rotated in increments of 15' and low power sonications, 30
watts, were performed for 20 seconds at each position.
Again, temperature images were used to visualize the foci.
For all in vivo experiments, ultrasound ablation was performed in thigh muscle of anesthetized male New Zealand white rabbits. In three rabbits, a series of high power 30-second. sonications, 130-160 watts each, were used to create large continuous lesions in thigh muscle. These lesions were generated by 8-24 3 cmdeep foci. The constant depth foci were spaced electrically by phasing and mechanically by rotation such that large lesions could be produced. The sonications were separated by at least one minute of cooling time to minimize near-field tissue damage. Following the ablation experiments, the animal was the lesion size was quantified from gross histology. Figure 2 , left image, shows the axial range of the transducer. The figure shows 6 separate sonications superimposed in one image in an image plane parallel to the array face, but 4 cm from the face. This image demonstrates that the phased array can cover a 5.5 cm length along its axial dimension. Note that the intensities of the -1 cm, -1.5 cm, and the -2 cm foci are higher than the others. This is due to the array being slightly tilted in the AR-plane. 
RESULTS
Fabrication Materials
In Vivo Experiments
Three large-volume lesions were created in vivo in rabbit thigh muscle. Table 2 shows the sonication parameters and the resulting lesion size for each treatment. Lesion size is noted in radial x axial x transverse dimensions. Side effects of each treatment are also listed in the table. Treatment 1 produced the largest lesion, but had the most severe side effects: edema and skin bum. In this treatment, the sonications were spaced in 3-5 mm intervals and almost every position was sonicated twice. The smallest lesion was created in treatment 2. This treatment consisted of 8 130-watt sonications regularly spaced in 5 mm intervals within the target volume. Treatment 2 (shown in Figure 3) had no distinguishable side effects. Treatment 3 consisted of 12 150-watt sonications spaced in 5 mm intervals. In contrast to the other treatments, each sonication was initiated immediately after the one minute cooling time. The complete treatment was conducted in less than 20 minutes. Mild edema was noted at the completion of this treatment. Edema Mild -volume 5.5 cm x 6 cm x 3 cm (axial x transverse x radial). The major side effects of large volume ablation were edema and skin bum caused by near field heating. These are serious concerns since these effects would translate into rectal wall heating in prostate treatments. Edema in the near field and skin bum were prominent in the first treatment. The cause of near field heating in this treatment was probably due to too many sonications within a targeted volume with too short interval between the sonications. The third treatment had no skin bum and only mild edema. Side effects in this treatment are most likely caused by high powers. In the treatments that had edema, powers greater than 130 watts were used. Treatment 2, which had no side effects, was performed with 120-watt sonications. In addition, short cooling times could be the cause of near field heating. These times could be extended to minimize thermal dose accumulation in the near field [9] . This study has demonstrated the feasibility of whole prostate ablation in a practical time with a MRIcompatible phased array. Sufficient powers for large volume ablation could be reliably achieved with this linear phased array. However, before this device can be used for clinical treatments, more work needs to be done to optimize sonication protocols. 
DISCUSSION
The large range of the intracavitary phased array has been demonstrated by the ex vivo experiments. The results indicate that foci can be created in a
